News & Analysis on Clinical Trial Services & Contract Research And Development
A new understanding of specialised gut hormones may lead to advances in the treatment and management of type 2 diabetes, offering patients a viable option in controlling fluctuating blood glucose levels that is characteristic of the disease.
Digital imaging specialists Nikon has launched a new spectral detector that captures images faster with a single scan over the full spectral range. The quality of images obtained from multiple fluorescence probes within a sample will have numerous...
In the wake of the latest American Society of Clinical Oncology's (ASCO) annual conference, drug companies from around the world showcased potential drug treatments, with a number of new molecular targets as well as therapy strategies for cancer.
Biotechnology company, Affitech, has entered into a collaboration agreement for two promising new cancer-specific human antibodies using its Cell-Based Antibody Selection technology (CBAS).
A single injection could replace implants for some drugs that require continuous administration, according to preliminary experiments with a novel drug delivery technology, reports Phil Taylor.
Nanotechnology has the potential to radically alter the quality and cleanliness of laboratory and pharmaceutical workplaces.
Switzerland's Siegfried Group, a specialist in active pharmaceutical ingredients (APIs), dosage forms and biopharmaceuticals, has boosted its position in the production of controlled substances with the acquisition of US-based Penick Corporation in a...
Rohm and Haas' Advanced Biosciences division has launched a new product in its Amberchrom range of chromatographic resins that can replace and improve on silica in the final stages of biologics purification.